[1]李卫校,崔明哲,李 强,等.经肠系膜上静脉肝外门体分流术治疗门静脉海绵样变性1例 [J].介入放射学杂志,2021,30(09):960-963.
 LI Weixiao,CUI Mingzhe,LI Qiang,et al.Transmesenteric vein extrahepatic portosystemic shunt for the treatment of cavernous transformation of the portal vein: report of one case[J].journal interventional radiology,2021,30(09):960-963.
点击复制

经肠系膜上静脉肝外门体分流术治疗门静脉海绵样变性1例
()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
30
期数:
2021年09
页码:
960-963
栏目:
病例报告
出版日期:
2021-09-25

文章信息/Info

Title:
Transmesenteric vein extrahepatic portosystemic shunt for the treatment of cavernous transformation of the portal vein: report of one case
作者:
李卫校 崔明哲 李 强 宋德洋 陈江波 逯党辉 张东宾 翟水亭
Author(s):
LI Weixiao CUI Mingzhe LI Qiang SONG Deyang CHEN Jiangbo LU Danghui ZHANG Dongbin ZHAI Shuiting.
Department of Vascular Surgery, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital, Zhengzhou, Henan Province 450003, China
关键词:
【关键词】 门静脉海绵样变性 肝硬化 门体分流术 肠系膜上静脉
文献标志码:
A

参考文献/References:

[1] Balfour GW, Stewart TG. Case of enlarged spleen complicated with ascites, both depending upon varicose dilatation and thrombosis of the portal vein[J]. Edinb Med J, 1869, 14: 589-598.
[2] Valla DC, Condat B, Lebrec D. Spectrum of portal vein thrombosis in the West[J]. J Gastroenterol Hepatol, 2002, 17 (Suppl 3): S224-S227.
[3] Garcia-Pagan JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding[J]. N Engl J Med, 2010, 362: 2370-2379.
[4] 唐世伟,赵新建,王忠敏,等. TIPS对比EBL治疗肝硬化食管静脉曲张出血Meta分析[J]. 介入放射学杂志, 2016, 25:761-765.
[5] 李培杰,徐 菁,闫丽晶,等. 经颈静脉肝内门体分流术与药物联合内镜治疗肝硬化食管胃静脉曲张出血患者五年生存状况比较[J]. 中华消化杂志, 2021, 41:323-329.
[6] Haskal ZJ, Duszak R Jr, Furth EE. Transjugular intrahepatic transcaval portosystemic shunt: the gun- sight approach[J]. J Vasc Interv Radiol, 1996, 7: 139-142.
[7] 李国宏,冯英璞,李双喜,等. 门脉高压患者门体支架植入围术期营养管理专家共识(2020)[J]. 介入放射学杂志, 2021, 30:217-224.
[8] 马鹍鹏,梁松年,钟红珊,等. Viatorr支架行TIPS术治疗门静脉高压性静脉曲张消化道出血效果评估[J]. 介入放射学杂志, 2020, 29:380-384.
[9] Li LN, Sun XY, Wang GC, et al. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival[J]. J Dig Dis, 2019, 20: 89-96.
[10] Qi X, Han G, Yin Z, et al. Transjugular intrahepatic portosys-temic shunt for portal cavernoma with symptomatic portal hypertension in non- cirrhotic patients[J]. Dig Dis Sci, 2012, 57: 1072-1082.
[11] 叶 鹏,陈 勇,赵剑波,等. 球囊辅助经颈静脉肝内门体静脉分流术治疗症状性完全闭塞型慢性门静脉血栓[J]. 中华放射学杂志, 2014, 48:958-960.
[12] Habib A, Desai K, Hickey R, et al. Portal vein recanalization-transjugularintrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis[J]. J Vasc Interv Radiol, 2015, 26: 499-506.
[13] Kallini JR, Gabr A, Kulik L, et al. Noncirrhotic complete obliterative portal vein thrombosis: novel management using trans- splenic transjugular intrahepatic portosystemic shunt with portal vein recanalization[J]. Hepatology, 2016, 63: 1387-1390.
[14] Hepatobiliary Disease Study Group,Chinese Society of Gastroen-terology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis(2020,Shanghai)[J]. J Dig Dis, 2021, 22: 176-186.
[15] Farsad K, Zaman A. Percutaneous transmesenteric portal vein recanalization and transjugular direct intrahepatic portosystemic shunt creation for chronic portal vein occlusion[J]. J Vasc Interv Radiol, 2019, 30: 892-893.
[16] Matsui O, Yoshikawa J, Kadoya M, et al. Transjugular intrahepatic portosystemic shunt after previous recanalization of a chronically thrombosed portal vein via a transmesenteric approach[J]. Cardiovasc Intervent Radiol, 1996, 19: 352-355.
[17] Sabri SS, Caldwell SH, Kumer SC, et al. Combined transme-senteric and transhepatic recanalization of chronic portal and mesenteric vein occlusion to treat bleeding duodenal varices[J]. J Vasc Interv Radiol, 2014, 25: 1295-1299.
[18] Bilbao JI, Elorz M, Vivas I, et al. Transjugular intrahepatic portosystemic shunt(TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non- cirrhotic patients[J]. Cardiovasc Intervent Radiol, 2004, 27: 474-480.
[19] Yamagami T, Takeuchi Y, Sonoyama T, et al. Non- cavernomatous superior mesenteric thrombosis successfully recanalized with interventional radiological procedures carried out with a combination transmesenteric and transjugular approaches[J]. Australas Radiol, 2006, 50: 495-499.

相似文献/References:

[1]贾雨辰,程红岩,陈栋,等.原发性肝癌的介入治疗[J].介入放射学杂志,1997,(02):113.
[2]滕皋军,Michael A Bettmann,Robert F Jeffery,等.经颈内静脉肝内门腔分流术远期疗效分析[J].介入放射学杂志,1997,(03):149.
[3]陆莎莎,程永德.动脉灌注化疗与栓塞治疗肝癌后声像图变化的探讨[J].介入放射学杂志,1992,(01):43.
[4]黄祥龙,张子曙,沈天真,等.经颈静脉肝内门体分流术的初步临床体会[J].介入放射学杂志,1994,(02):69.
[5]杨建勇,RoerenTH,RichterGM,等.TIPSS技术与Richter穿刺针——150例临床应用的方法学讨论[J].介入放射学杂志,1994,(04):189.
[6]程永德,张福琛,金健行,等.原发性肝癌的诊断与介入性治疗[J].介入放射学杂志,1995,(01):39.
[7]玄祖旗,黄俊.简讯[J].介入放射学杂志,1995,(04):214.
[8]王建华,颜志平,王小林,等.肝癌介入治疗若干问题探讨[J].介入放射学杂志,1996,(01):3.
[9]俞文强,刘子江,袁建华,等.晚期肝癌患者生存二年以上的治疗体会[J].介入放射学杂志,1996,(01):44.
[10]徐光如,张明辉,朱红星,等.磁共振ADC值评价肝硬化合并肝癌介入治疗后肝功能储备的初步研究[J].介入放射学杂志,2013,(01):36.
 XU Guang? ru,ZHANG Ming? hui,ZHU Hong? xing,et al. The application of MR?蛳 ADC value in evaluating the liver function reserve in patients with cirrhosis complicated by hepatic cancer after interventional treatment: a preliminary study[J].journal interventional radiology,2013,(09):36.

备注/Memo

备注/Memo:
(收稿日期:2021-06-24)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2021-09-13